• Loading stock data...
Est. 2004

LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Wednesday 09/19/2018
SMALL CAP MARKET NEWS

We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.


LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!

Stock Investors · Accredited Investors · Hedge Fund Investors

Learn More

Pressure BioSciences

  • 3:22 PM

    REDONDO BEACH, CA–(Marketwired – Nov 21, 2016) – SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article covering Pressure BioSciences Inc.’s (OTCQB: PBIO) recently announced financial results, how these record results were achieved, and where the company is headed in the near future. Pressure BioSciences recorded record product and service revenue that increased 4% to $500,949 during the third quarter driven by a 13% increase in instrument sales. At the

    Read more
  • 3:51 PM

    Investors in Final Close Include All Five Board Members SOUTH EASTON, Mass., April 7, 2016, PBIO, /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling, pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced the receipt of $769,667 in the final close of its $5 Million PIPE Financing (the “Offering”). This final closing increased the total raised in the Offering to $6,329,667, an

    Read more
  • 3:56 PM

    SOUTH EASTON, Mass., Jan. 11, 2016, PBIO, /PRNewswire/ — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” and the “Company”), a leader in the development and sale of broadly enabling, pressure cycling technology (“PCT”)-based sample preparation solutions to the worldwide life sciences industry, today announced it has exceeded its $5 million PIPE goal following the receipt of $255,000 in gross proceeds from the fifth closing of its $5 million Private Placement (the “Offering”). This closing increased the total amount raised in the

    Read more
  • 1:11 PM

    Oct 01, 2015 OTC Disclosure & News Service – NEW YORK, Oct. 1, 2015, OTCQB, LLTP, (GLOBE NEWSWIRE) — Lightlake Therapeutics Inc. (“Lightlake”) (OTCQB:LLTP), a specialty pharmaceutical company developing pharmacological treatments for substance use, addictive, and eating disorders, announced today that it has received a second funding commitment from a prominent international research and development foundation. The foundation has a focus on promoting innovative research-based initiatives, including those addressing health issues. Lightlake has been planning studies that could potentially advance multiple

    Read more
  • Dario Logo
    2:12 PM

    Investors include company officers, employees, friends & family; Participating high net worth private investors include current shareholders and a new investment by Shmuel Farhi PR Newswire CAESAREA, Israel, Aug. 31, 2015 CAESAREA, Israel, Aug. 31, 2015, OTCQB, DRIO, /PRNewswire/ — LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it recently closed a round of funding totaling approximately $2.5 million. Funds will be used to support the global rollout and initial U.S. commercial launch of

    Read more
  • 3:54 PM

    Past IP Rates in the Area Show Significant Potential for the Lease DALLAS, Oct 09, 2014 (GLOBE NEWSWIRE via COMTEX) — LIG Assets, Inc. (OTCPK:LIGA) today announced that its wholly owned subsidiary, CP Resources, LLC, has executed an option to acquire lease interest and drilling interest in 400 acres in leases located in the Permian Basin. Wells are planned for the lease and are intended to go down to a depth of approximately 8000 to 9000 feet and would be

    Read more
Public Wire Banner